Insider · CIK 0001401267
Hoyoung Huh
directorowner
Files at AKTX (Akari Therapeutics Plc), PLRX (PLIANT THERAPEUTICS, INC.), PKBO (Peak Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Common Stock (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 9, 2025 |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +892,857 | $1.12 | $1000k | 4,695,854 | Mar 10, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Series A Warrants (Right to Buy)derivative | +892,857 | $1.12 | $1000k | 892,857 | Mar 10, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Series B Warrants (Right to Buy)derivative | +892,857 | $1.12 | $1000k | 892,857 | Mar 10, 2025 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | CConversion Common Stock | +4,574,661 | - | - | 4,574,661 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | DDisposition to issuer Common Stock | -4,574,661 | - | - | 0 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | DDisposition to issuer Common Stock | -8,382,742 | - | - | 0 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | DDisposition to issuer Common Stockindirect: See footnote | -372,940 | - | - | 0 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | CConversion Convertible Notesderivative | - | - | - | 0 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | DDisposition to issuer Warrant (Right to Purchase)derivative | -176,292 | - | - | 0 | Nov 18, 2024 |
| Nov 14, 2024 | PKBO Peak Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,200,000 | $0.00 | $0 | 0 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.